{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:16:20Z","timestamp":1777299380879,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":5747,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009980","name":"Medizinische Universit\u00e4t Innsbruck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.fertnstert.2006.01.039","type":"journal-article","created":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T08:34:14Z","timestamp":1155112454000},"page":"651-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women"],"prefix":"10.1016","volume":"86","author":[{"given":"Dijana","family":"Had\u017eiomerovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Rabenbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Wildt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2006.01.039_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"Syndromes of insulin resistance and acanthosis nigricans\u2014insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(83)90091-1","article-title":"Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome\u2014a common endocrinopathy with distinct pathophysiologic features","volume":"147","author":"Barbieri","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.me.42.020191.001215","article-title":"Polycystic ovarian disease","volume":"42","author":"Barbieri","year":"1991","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","article-title":"On the paradox of insulin-induced hyperandrogenism in insulin-resistant states","volume":"12","author":"Poretsky","year":"1991","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/edrv-8-2-132","article-title":"The gonadotropic function of insulin","volume":"82","author":"Poretsky","year":"1987","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/oxfordjournals.humrep.a137482","article-title":"Effect of opiate receptor blockade on the insulin-response to oral glucose load in polycystic ovarian disease","volume":"6","author":"Lanzone","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib7","first-page":"1049","article-title":"Relationship between insulin resistance, LH secretion and ovarian morphological changes, in women with polycystic ovary syndrome","volume":"126","author":"Sir-Petermann","year":"1998","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0029-1212004","article-title":"Naltrexone effects on sensitivity and insulin secretion in hyperandrogenic women","volume":"106","author":"Sir-Petermann","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/jcem-50-5-975","article-title":"Beta-endorphin and beta-lipotropin plasma-levels in hirsute women\u2014correlation with body weight","volume":"50","author":"Givens","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/humrep\/8.suppl_2.168","article-title":"Opiate antagonist treatment of ovarian failure","volume":"8","author":"Wildt","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-8227(90)90040-Z","article-title":"Insulin release and peripheral sensitivity at the oral glucose tolerance test","volume":"10","author":"Cederholm","year":"1990","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/oxfordjournals.humrep.a138050","article-title":"Treatment with naltrexone in hypothalamic ovarian failure\u2014induction of ovulation and pregnancy","volume":"8","author":"Wildt","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0166-2236(84)80009-0","article-title":"Endogenous opioid peptides and the menstrual cycle","volume":"7","author":"Ferin","year":"1984","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib14","first-page":"441","article-title":"The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides","volume":"40","author":"Ferin","year":"1984","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1055\/s-2007-1013546","article-title":"Effects of naloxone-induced opiate receptors blockade on insulin secretion in obesity","volume":"17","author":"Vettor","year":"1985","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/jcem-64-2-377","article-title":"Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans","volume":"64","author":"Givens","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0015-0282(02)02955-2","article-title":"Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome","volume":"77","author":"Fruzzetti","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.fertnstert.2003.05.036","article-title":"Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study","volume":"81","author":"Cucinelli","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/jcem-49-4-649","article-title":"Beta-endorphin in the human pancreas","volume":"49","author":"Bruni","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1056\/NEJM198307073090118","article-title":"Beta-endorphin and the endocrine pancreas\u2014reply","volume":"309","author":"Feldman","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-2007-1011863","article-title":"Dual effect of beta-endorphin on insulin secretion in man","volume":"19","author":"Giugliano","year":"1987","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/jcem-69-4-790","article-title":"Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans\u2014application of a combined model of insulin and C-peptide kinetics","volume":"69","author":"Watanabe","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/edrv-6-1-45","article-title":"Assessment of insulin sensitivity in vivo","volume":"6","author":"Bergman","year":"1985","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib24","first-page":"191","article-title":"Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease","volume":"82","author":"Fulghesu","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib25","first-page":"942","article-title":"Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.2001.01303.x","article-title":"Tissue insulin sensitivity and body weight in polycystic ovary syndrome","volume":"55","author":"Marsden","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0026-0495(99)90028-8","article-title":"Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome","volume":"48","author":"Ciampelli","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib29","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1210\/jcem.83.5.4775","article-title":"Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome","volume":"83","author":"Guido","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib30","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib31","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/jcem-64-5-960","article-title":"Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids","volume":"64","author":"Cohen","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/jcem-70-3-699","article-title":"Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome","volume":"70","author":"Dunaif","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib33","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0002-9378(87)80319-8","article-title":"Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus-monkeys","volume":"157","author":"Billiar","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0002-9378(86)90410-2","article-title":"Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries","volume":"154","author":"Pasquali","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib35","first-page":"921","article-title":"Persistent insulin resistance after normalization of androgen levels in a woman with congenital adrenal hyperplasia\u2014a case report","volume":"34","author":"Singer","year":"1989","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-2007-1009272","article-title":"Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease","volume":"21","author":"Mahabeer","year":"1989","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/diacare.13.6.631","article-title":"Insulin and atheroma\u201420-yr perspective","volume":"13","author":"Stout","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/clinchem\/36.2.283","article-title":"Lipoprotein lipids in women with androgen excess\u2014independent associations with increased insulin and androgen","volume":"36","author":"Wild","year":"1990","journal-title":"Clin Chem"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib39","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI114868","article-title":"Elevated insulin-receptor content in human breast cancer","volume":"86","author":"Papa","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib40","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0002-8703(91)90432-H","article-title":"The epidemiology of impaired glucose tolerance and hypertension","volume":"121","author":"Kannel","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib41","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0015-0282(99)00401-X","article-title":"Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors","volume":"72","author":"Legro","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib42","first-page":"2975","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome\u2014authors\u2019 response","volume":"84","author":"Dunaif","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2006.01.039_bib43","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028206009204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028206009204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:27:17Z","timestamp":1777296437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028206009204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0015028206009204"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2006.01.039","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2006.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}